These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2109780)

  • 1. Production of interferon-gamma by in vivo tumor-sensitized T cells: association with active antitumor immunity.
    Bursuker I; Pearce MT
    J Interferon Res; 1990 Feb; 10(1):1-11. PubMed ID: 2109780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication of syngeneic tumor (Meth A fibrosarcoma) from mice by adoptive immunotherapy of immunized spleen cells induced by Corynebacterium parvum-pyridine extract residue.
    Mukai K; Horimi T; Orita K
    Acta Med Okayama; 1988 Dec; 42(6):301-10. PubMed ID: 3266420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells.
    Zou JP; Yamamoto N; Fujii T; Takenaka H; Kobayashi M; Herrmann SH; Wolf SF; Fujiwara H; Hamaoka T
    Int Immunol; 1995 Jul; 7(7):1135-45. PubMed ID: 8527411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells.
    Bianchi R; Fioretti MC; Romani L; Grohmann U; Cenci E; Puccetti P
    Int J Cancer; 1990 Oct; 46(4):653-7. PubMed ID: 2120136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo antitumor effects of murine interferon-gamma-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites.
    Micallef MJ; Yoshida K; Kawai S; Hanaya T; Kohno K; Arai S; Tanimoto T; Torigoe K; Fujii M; Ikeda M; Kurimoto M
    Cancer Immunol Immunother; 1997 Jan; 43(6):361-7. PubMed ID: 9067408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role of interferon-gamma (IFN-gamma) in tumor immunity: T cells with the capacity to reject tumor cells are generated but fail to migrate to tumor sites in IFN-gamma-deficient mice.
    Nakajima C; Uekusa Y; Iwasaki M; Yamaguchi N; Mukai T; Gao P; Tomura M; Ono S; Tsujimura T; Fujiwara H; Hamaoka T
    Cancer Res; 2001 Apr; 61(8):3399-405. PubMed ID: 11309299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effector phenotypes and mechanisms of antitumor immune reactivity of tumor-immunized and tumor-bearing mice in two syngeneic tumors.
    Fuyama S; Komatsu H; Arai S
    Cell Immunol; 1991 Oct; 137(1):200-15. PubMed ID: 1679379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells.
    Li T; Harada M; Tamada K; Abe K; Nomoto K
    Anticancer Res; 1997; 17(6D):4259-68. PubMed ID: 9494518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
    Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
    Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of antitumor mononuclear blood cells in tumor-bearing mice by interferon-alpha A/D therapy.
    Honjo K; Suhara Y; Taniyama T; Kataoka T
    J Interferon Res; 1990 Apr; 10(2):191-202. PubMed ID: 2341749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of astaxanthin and its mode of action.
    Jyonouchi H; Sun S; Iijima K; Gross MD
    Nutr Cancer; 2000; 36(1):59-65. PubMed ID: 10798217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mode of recognition of tumor antigens by noncytolytic-type antitumor T cells: role of antigen-presenting cells and their surface class I and class II H-2 molecules.
    Sakamoto K; Nakajima H; Shimizu J; Katagiri T; Kiyotaki C; Fujiwara H; Hamaoka T
    Cancer Immunol Immunother; 1988; 27(3):261-6. PubMed ID: 3141057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of T cells in lymphoid organs induced by interferon in tumor-bearing mice.
    Kataoka T; Honjo K; Oh-Hashi F; Murayama NM; Suhara Y
    J Interferon Res; 1990 Apr; 10(2):161-71. PubMed ID: 2341748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concanavalin A-induced interferon gamma production by murine spleen cells and T cell lines. Lack of correlation with Lyt 1,2 phenotype.
    Marcucci F; Klein B; Altevogt P; Landolfo S; Kirchner H
    Immunobiology; 1984 May; 166(3):219-27. PubMed ID: 6429036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and role of CD14 in mice sensitized to lipopolysaccharide by Propionibacterium acnes.
    Merlin T; Woelky-Bruggmann R; Fearns C; Freudenberg M; Landmann R
    Eur J Immunol; 2002 Mar; 32(3):761-72. PubMed ID: 11870620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
    Mizushima Y; Morikage T; Hirata H; Sato M; Sakamoto K; Yano S
    J Biol Response Mod; 1988 Aug; 7(4):371-83. PubMed ID: 3139841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of interferon-gamma production in killed BCG-pretreated mice after stimulation with staphylococcal enterotoxin A].
    Mizukoshi N; Ishihara C; Yamamoto K; Kato K
    Kekkaku; 1989 Aug; 64(8):499-509. PubMed ID: 2509777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological consequences of tumor excision: from active immunity to immunological memory.
    Bursuker I; North RJ
    Int J Cancer; 1986 Feb; 37(2):275-81. PubMed ID: 3943923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the antitumor activities of pyrimidinone-interferon inducers. Part 2. Potentiation of antitumor resistance mechanisms.
    Milas L; Hunter N; Ito H; Lotzová E; Stringfellow DA
    Clin Exp Metastasis; 1983; 1(3):213-22. PubMed ID: 6336272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade: the effect is manifested only at the restricted tumor-bearing stages.
    Yang YF; Zou JP; Mu J; Wijesuriya R; Ono S; Walunas T; Bluestone J; Fujiwara H; Hamaoka T
    Cancer Res; 1997 Sep; 57(18):4036-41. PubMed ID: 9307290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.